Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

Estimated Value: $1,500,000
Open New Healthcaregrant
Nov 5, 2026
—
Healthcare
grant

Key questions

Who can bid?

No set-aside is listed on the notice. Check the solicitation documents for vendor registration and eligibility requirements.

What kind of solicitation is it?

Grant in the Healthcare category.

How do I respond?

Responses go through the agency's official posting on grants.gov. BidsNexus links to the original solicitation and its documents; a free account shows the link and emails you similar bids.

AI Summary
This is a grant opportunity (U01 Clinical Trial Not Allowed) from HHS-NIH11 to fund research on understanding Type 1 Diabetes triggers, discovering early biomarkers, and developing new therapeutic strategies using NAMs (New Approach Methodologies). Applicants are expected to propose innovative research projects in this area.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Research Project: Leveraging NAMs for Type 1 Diabetes Disease Trigger Understanding 1 project $500,000.00 $500,000.00 Professional Services
Research Project: Leveraging NAMs for Early Biomarker Discovery in Type 1 Diabetes 1 project $500,000.00 $500,000.00 Professional Services
Research Project: Leveraging NAMs for Development of New Therapeutic Strategies for Type 1 Diabetes 1 project $500,000.00 $500,000.00 Professional Services
Estimated Bid Value$1,500,000.00

Want the full details?

Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.

Sign Up Free → Already have an account? Log in

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids